ACADIA Pharmaceuticals Inc — キャッシュフロー (NASDAQ:ACAD) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -136.17 M-125.66 M-114.03 M16.7 M157.72 M109.84 M 109.84 M 投資活動によるキャッシュフロー 192.51 M-71.1 M73.24 M32 M-30.54 M-302.56 M -302.56 M 財務活動によるキャッシュフロー 81 M18.16 M8.2 M25.13 M6.84 M49.88 M 49.88 M フリーキャッシュフロー -143.75 M-126.78 M-114.03 M-23.35 M157.2 M6.31 M 6.61 M

ACADIA Pharmaceuticals Inc

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

ニュース

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?

Biotech Is Holding Steady In 2026 (NASDAQ:IBB)

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

JAZZ or ACAD: Which Is the Better Value Stock Right Now?

Acadia Pharmaceuticals、Jonathan M. Pooleを取締役会に任命

Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)

ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU

BofAがAcadia Pharmaceuticalsの目標株価を引き下げ、欧州での後退を受けて